IP Library Patent Application 19399492
Patent Application
App. No. 19/399,492

METHODS FOR TARGETED SEQUENCING OF CELL-FREE DNA

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
19/399,492
Abstract

The invention provides methods for simultaneously enriching multiple target regions of interest in one reaction volume, from cell-free DNA isolated from a blood or plasma sample, followed by high-thought sequencing and sequence read analysis. The invention also provides library of target-specific oligonucletotide primers or probes for the multiplexed target enrichment.

Claims (30)

1 . A method for targeted sequencing of cell-free DNA, comprising:

appending at least one adaptor to cell-free DNA extracted from a blood or plasma sample of a human subject to generate adapted DNA;

performing targeted enrichment on the adapted DNA, wherein the targeted enrichment comprises (i) contacting adapted DNA with a library comprising oligonucleotides that specifically hybridize to at least 800 different target loci, wherein a target locus comprises a variant position, and (ii) amplifying adapted DNA that was contacted in step (i) in the same reaction volume to generate enriched DNA; and

determining the sequence of at least some of the enriched DNA or DNA derived therefrom by performing high-throughput sequencing to generate sequence reads.

2 . The method of claim 1 , wherein the method further comprises analyzing the sequence reads and identifying one or more variants from the sequence reads.

3 . The method of claim 1 , wherein the cell-free DNA comprises cell-free DNA derived from both normal and cancer cells of the human subject.

4 . The method of claim 1 , wherein the library comprises oligonucleotides that specifically hybridize to at least 1,200 different target loci comprising single nucleotide variant positions on one or more chromosomes.

5 . The method of claim 1 , wherein the library comprises oligonucleotides that specifically hybridize to 1,000 to 20,000 different target loci comprising single nucleotide variant positions on one or more chromosomes.

6 . The method of claim 1 , wherein the library comprises oligonucleotides that specifically hybridize to 1,000 to 10,000 different target loci comprising single nucleotide variant positions on one or more chromosomes.

7 . The method of claim 1 , wherein the concentration of each target locus-specific oligonucleotide in the library is 5 nM or less.

8 . The method of claim 1 , wherein the high-throughput sequencing is sequencing-by-synthesis.

9 . The method of claim 1 , wherein at least 90% of the sequence reads comprise the variants at loci specifically hybridized by the oligonucleotides.

10 . The method of claim 1 , wherein at least 95% of the sequence reads comprise the variants at loci specifically hybridized by the oligonucleotides.

11 . The method of claim 1 , wherein the at least one adaptor comprises a universal priming sequence.

12 . The method of claim 11 , wherein the method further comprises amplifying adapted DNA using the universal priming sequence prior to performing targeted enrichment.

13 . A method for targeted sequencing of cell-free DNA, comprising:

tagging cell-free DNA extracted from a biological sample from a human subject with molecular barcodes to generate tagged DNA;

performing targeted enrichment on the tagged DNA, wherein the targeted enrichment comprises (i) contacting tagged DNA with a library comprising oligonucleotides that specifically hybridize to at least 800 different target loci, wherein a target locus comprises a variant position, and (ii) amplifying tagged DNA that was contacted in step (i) in the same reaction volume to generate enriched DNA;

determining the sequence of at least some of the enriched DNA or DNA derived therefrom by performing high-throughput sequencing to generate sequence reads.

14 . The method of claim 13 , wherein the method further comprises analyzing the sequence reads and identifying one or more variants from the sequence reads.

15 . The method of claim 13 , wherein the cell-free DNA comprises cell-free DNA derived from both normal and cancer cells of the human subject.

16 . The method of claim 13 , wherein the library comprises oligonucleotides that specifically hybridize to at least 1,200 different target loci comprising single-nucleotide-variant positions on one or more chromosomes.

17 . The method of claim 13 , wherein the library comprises oligonucleotides that specifically hybridize to 1,000 to 20,000 different target loci comprising single-nucleotide-variant positions on one or more chromosomes.

18 . The method of claim 13 , wherein the library comprises oligonucleotides that specifically hybridize to 1,000 to 10,000 different target loci comprising single-nucleotide-variant positions on one or more chromosomes.

19 . The method of claim 13 , wherein the concentration of each target-specific oligonucleotide in the library of target-specific oligonucleotides is 5 nM or less.

20 . The method of claim 13 , wherein the high-throughput sequencing is sequencing-by-synthesis.

21 . The method of claim 13 , wherein at least 90% of the sequence reads comprises the variants at loci specifically hybridized by the oligonucleotides.

22 . The method of claim 13 , wherein at least 95% of the sequence reads comprises the variants at loci specifically hybridized by the oligonucleotides.

23 . The method of claim 13 , wherein the tagged DNA are tagged with up to 1024 different molecular barcodes.

24 . The method of claim 13 , wherein the tagged DNA are tagged with 1024 to 65536 different molecular barcodes.